Kamagra repose sur le sildénafil comme principe actif, avec un mode d’action identique à celui du Viagra. La forme galénique en gel oral permet une absorption plus rapide et une concentration plasmatique maximale plus précoce que les comprimés. Le mécanisme implique l’inhibition compétitive de la PDE5, entraînant une relaxation musculaire lisse locale et une vasodilatation ciblée. La demi-vie courte, environ 4 heures, limite la durée d’action. L’élimination se fait après métabolisme hépatique, impliquant majoritairement le CYP3A4. L’incidence d’effets indésirables comprend céphalées, rougeurs et congestion nasale, de façon transitoire. Dans les comparatifs pharmacologiques, acheter kamagra sans ordonnance est associé aux présentations galéniques alternatives disponibles.

Publikationsliste

1. Wilke A, Wende C, Horst M, Steverding D: Thrombosis of a prosthetic mitral valve after withdrawal of phenprocoumon therapy. Cardiol Res 2011 (in print) 2. Diepholz D, Wilke A, Maisch B, Steverding D: Demonstration of TGF- β and XIII α in Endocardial Biopsies of Carcinoid Heart Disease Patients: an Immunofluorescence Study. Cardiol Res 2011;2(3):119-122 3. Wilke A, Steverding D: Does the Cardiologist play a Key Role in the Management of Hypertension? Cardiol Res 2011;2(2):79-81 4. Wilke A, Dapunt O, Steverding D: Bluish Pigmentation of the Sclera and the Aortic Valve in a Patient with Alkaptonuric Ochronosis. Herz. 2010 Jan;35(1):41 5. Wilke A, Steverding D: Ochronosis as an unusual cause of valvular defect: a case report. J 6. Schuchert A, Rebeski HP, Peiffer T, Bub E, Dietz A, Mortensen K, Aydin MA, Camm J, Gazarek S, Meinertz T; Leonhardt V, Ebner E, Hartung W, Schneider W, Wilke A, Müller M, Lang A, Schwerdt RC, Schöning F.: Effects of continuous and triggered atrial overdrive pacing on paroxysmal atrial fibrillation in pacemaker patients; Pacing Clin 7. Portig I, Wilke A, Freyland M, Wolf MJ, Richter A, Ruppert V, Pankuweit S, Maisch B;.; Familial inflammatory dilated cardiomyopathy; Eur J Heart Fail. 2006 Dec;8(8):816-25 8. Diepholz D, Stuhn-Pfeifer HJ, Wilke A: An unusual reason for a diastolic murmur. Herz. 9. Wilke A, Noll B, Maisch B.;Recurrent ventricular fibrillation after defibrillation in a patient with pacemaker;Med Klin (Munich). 2000 Sep 15;95(9):523-6. 10. Wilke A, Noll B, Maisch B.;Angina pectoris in extracoronary diseases;Herz. 1999 11. Wilke A, Kruse T, Hesse H, Funck R, Maisch B.;Risk of interference between pacemakers and security systems.;Pacing Clin Electrophysiol. 1999 Mar;22(3):540 12. Mestroni L, Maisch B, McKenna WJ, Schwartz K, Charron P, Rocco C, Tesson F, Richter A, Wilke A, Komajda M.;Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy;Eur Heart J. 1999 Jan;20(2):93-102. 13. Wilke A, Hesse H, Gorg C, Maisch B.;Elevation of the pacing threshold: a side effect in a patient with pacemaker undergoing therapy with doxorubicin and vincristine.;Oncology. 14. Wilke A, Maisch B.;Sources of interference for cardiac pacemakers. Technical improvements of pacemakers--risks in the medical realm;Fortschr Med. 1998 Aug 15. Wilke A, Kruse T, Maisch B.;Angina pectoris in leiomyoma;Herz. 1998 Aug;23(5):299- 16. Wilke A, Kruse T, Hesse H, Funck R, Maisch B.;Interactions between pacemakers and security systems.;Pacing Clin Electrophysiol. 1998 Sep;21(9):1784-8 17. Wilke A, Kruse T, Hesse H, Bittinger A, Moosdorf R, Maisch B.;Papillary muscle injury after blunt chest trauma.;J Trauma. 1997 Aug;43(2):360-1 18. Wilke A, Kruse T, Funck R, Maisch B.;Risk factors for pacemaker disorders;Dtsch Med 19. Wilke A, Hesse H, Hufnagel G, Maisch B.;Mitral, aortic and tricuspid valvular heart disease associated with ergotamine therapy for migraine.;Eur Heart J. 1997 Apr;18(4):701 20. Funck RC, Wilke A, Rupp H, Brilla CG.;Regulation and role of myocardial collagen matrix remodeling in hypertensive heart disease.;Adv Exp Med Biol. 1997;432:35-44 21. Wilke A, Grimm W, Funck R, Maisch B.;Influence of D-net (European GSM-Standard) cellular phones on pacemaker function in 50 patients with permanent pacemakers.;Pacing Clin Electrophysiol. 1996 Oct;19(10):1456-8 22. Wilke A, Kaiser A, Ferency I, Maisch B.;Alcohol and myocarditis;Herz. 1996 23. Wilke A, Funck R, Rupp H, Brilla CG.;Effect of the renin-angiotensin-aldosterone system on the cardiac interstitium in heart failure.;Basic Res Cardiol. 1996;91 Suppl 2:79- 24. Funck RC, Wilke A, Rupp H, Maisch B, Brilla CG.;Cardiac structure-function relationship and the renin-angiotensin-aldosterone system in hypertensive heart 25. Wilke A, Grimm W, Kohler H, Maisch B.;Differential diagnostic challenge in pericardial effusion;Internist (Berl). 1995 Sep;36(9):909-11 26. Wilke A, Schonian U, Herzum M, Hengstenberg C, Hufnagel G, Brilla CG, Maisch B.;The extracellular matrix and cytoskeleton of the myocardium in cardiac inflammatory 27. Wilke A, Schmoll J.;Typical complications of short rib polydactyly syndrome;Klin Padiatr.

Source: http://www.kardiologie-papenburg.de/PDF/publikationsliste.pdf